Chemistry 3373F Lab Manual 2009
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Monoamine Oxydases Et Athérosclérose : Signalisation Mitogène Et Études in Vivo
UNIVERSITE TOULOUSE III - PAUL SABATIER Sciences THESE Pour obtenir le grade de DOCTEUR DE L’UNIVERSITE TOULOUSE III Discipline : Innovation Pharmacologique Présentée et soutenue par : Christelle Coatrieux le 08 octobre 2007 Monoamine oxydases et athérosclérose : signalisation mitogène et études in vivo Jury Monsieur Luc Rochette Rapporteur Professeur, Université de Bourgogne, Dijon Monsieur Ramaroson Andriantsitohaina Rapporteur Directeur de Recherche, INSERM, Angers Monsieur Philippe Valet Président Professeur, Université Paul Sabatier, Toulouse III Madame Nathalie Augé Examinateur Chargé de Recherche, INSERM Monsieur Angelo Parini Directeur de Thèse Professeur, Université Paul Sabatier, Toulouse III INSERM, U858, équipes 6/10, Institut Louis Bugnard, CHU Rangueil, Toulouse Résumé Les espèces réactives de l’oxygène (EROs) sont impliquées dans l’activation de nombreuses voies de signalisation cellulaires, conduisant à différentes réponses comme la prolifération. Les EROs, à cause du stress oxydant qu’elles génèrent, sont impliquées dans de nombreuses pathologies, notamment l’athérosclérose. Les monoamine oxydases (MAOs) sont deux flavoenzymes responsables de la dégradation des catécholamines et des amines biogènes comme la sérotonine ; elles sont une source importante d’EROs. Il a été montré qu’elles peuvent être impliquées dans la prolifération cellulaire ou l’apoptose du fait du stress oxydant qu’elles génèrent. Ce travail de thèse a montré que la MAO-A, en dégradant son substrat (sérotonine ou tyramine), active une voie de signalisation mitogène particulière : la voie métalloprotéase- 2/sphingolipides (MMP2/sphingolipides), et contribue à la prolifération de cellules musculaire lisses vasculaires induite par ces monoamines. De plus, une étude complémentaire a confirmé l’importance des EROs comme stimulus mitogène (utilisation de peroxyde d’hydrogène exogène), et a décrit plus spécifiquement les étapes en amont de l’activation de MMP2, ainsi que l’activation par la MMP2 de la sphingomyélinase neutre (première enzyme de la cascade des sphingolipides). -
Transport of Dangerous Goods
ST/SG/AC.10/1/Rev.16 (Vol.I) Recommendations on the TRANSPORT OF DANGEROUS GOODS Model Regulations Volume I Sixteenth revised edition UNITED NATIONS New York and Geneva, 2009 NOTE The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. ST/SG/AC.10/1/Rev.16 (Vol.I) Copyright © United Nations, 2009 All rights reserved. No part of this publication may, for sales purposes, be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, electrostatic, magnetic tape, mechanical, photocopying or otherwise, without prior permission in writing from the United Nations. UNITED NATIONS Sales No. E.09.VIII.2 ISBN 978-92-1-139136-7 (complete set of two volumes) ISSN 1014-5753 Volumes I and II not to be sold separately FOREWORD The Recommendations on the Transport of Dangerous Goods are addressed to governments and to the international organizations concerned with safety in the transport of dangerous goods. The first version, prepared by the United Nations Economic and Social Council's Committee of Experts on the Transport of Dangerous Goods, was published in 1956 (ST/ECA/43-E/CN.2/170). In response to developments in technology and the changing needs of users, they have been regularly amended and updated at succeeding sessions of the Committee of Experts pursuant to Resolution 645 G (XXIII) of 26 April 1957 of the Economic and Social Council and subsequent resolutions. -
Iodine(V) Reagents in Organic Synthesis. Part 4. O-Iodoxybenzoic Acid As a Chemospecific Tool for Single Electron Transfer-Based Oxidation Processes K
Published on Web 02/16/2002 Iodine(V) Reagents in Organic Synthesis. Part 4. o-Iodoxybenzoic Acid as a Chemospecific Tool for Single Electron Transfer-Based Oxidation Processes K. C. Nicolaou,* T. Montagnon, P. S. Baran, and Y.-L. Zhong Contribution from the Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, and Department of Chemistry and Biochemistry, UniVersity of California, San Diego, 9500 Gilman DriVe, La Jolla, California 92093 Received September 4, 2001 Abstract: o-Iodoxybenzoic acid (IBX), a readily available hypervalent iodine(V) reagent, was found to be highly effective in carrying out oxidations adjacent to carbonyl functionalities (to form R,â-unsaturated carbonyl compounds) and at benzylic and related carbon centers (to form conjugated aromatic carbonyl systems). Mechanistic investigations led to the conclusion that these new reactions are initiated by single electron transfer (SET) from the substrate to IBX to form a radical cation which reacts further to give the final products. Fine-tuning of the reaction conditions allowed remarkably selective transformations within multifunctional substrates, elevating the status of this reagent to that of a highly useful and chemoselective oxidant. Introduction In the preceding three papers,1-3 we have presented an array of useful transformations mediated by the iodine(V)-based reagents Dess-Martin periodinane (DMP), o-iodoxybenzoic acid (IBX), and Ac-IBX (see Figure 1). In the current paper, we expand on this theme with a description of a powerful new methodology which employs IBX for the facile and selective oxidation adjacent to carbonyl and aromatic moieties. -
Prof. J. Masson Gulland, F.R.S
702 NATURE November 22, 1947 Vol. 160 The general discussion was opened by Dr. W. K. Slater. He emphasized that the additional production OBITUARIES of food from sources in Great Britain means increased supplies of materials, for example, for additional Prof. J. Masson Gulland, F.R.S. factories and plant for extracting sugar-beet and for IT was with a sense of severe personal loss that housing poultry. The training of the human element his many friends learned of the untimely death of in more efficient methods of cultivation and of Prof. J. M. Gulland, who was a victim of the railway management of stock is likely to be a formidable accident at Goswick on October 26. He was a leading task. He asked whether a true appreciation of the figure in the chemical world, a pioneer worker in immediate future position in Great Britain is rather several important fields of organic chemistry and that the number of calories per person and the biochemistry, and a man of outstanding personal nutritional value of the average diet generally are charm. much more likely to fall than to rise ; and how far John Masson Gulland was born in Edinburgh in this fall could go without acute sequelre. 1898 and was the only son of the late Prof. G. Lovell Dr. N. C. Wright considered that a matter of Gulland, professor of medicine in the University of immediate importance is the prevention of wastage, Edinburgh. Gulland was much devoted to his native from whatever cause, of food already produced. We land, and above all to his native city, which ho must find out, for example, exactly what happens to frequently visited. -
Process for Producing Optically Active Tropinone Monocarboxylic Acid Derivative
Europäisches Patentamt *EP001118674A1* (19) European Patent Office Office européen des brevets (11) EP 1 118 674 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 158(3) EPC (43) Date of publication: (51) Int Cl.7: C12P 17/10 25.07.2001 Bulletin 2001/30 (86) International application number: (21) Application number: 99929794.8 PCT/JP99/03754 (22) Date of filing: 12.07.1999 (87) International publication number: WO 00/18946 (06.04.2000 Gazette 2000/14) (84) Designated Contracting States: • NAKAMURA, Soichi, Nihon Medi-physics K. K. AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU Sodegaura-shi, Chiba 299-0241 (JP) MC NL PT SE • NAKAMURA, Daisaku Ichihara-shi, Chiba 299-0115 (JP) (30) Priority: 30.09.1998 JP 27786898 (74) Representative: Keen, Celia Mary (71) Applicant: Nihon Medi-Physics Co., Ltd. J.A. Kemp & Co. Nishinomiya-shi, Hyogo 662-0918 (JP) 14 South Square Gray’s Inn (72) Inventors: London WC1R 5JJ (GB) • NODE, Manabu Hirakata-shi, Osaka 573-1118 (JP) (54) PROCESS FOR PRODUCING OPTICALLY ACTIVE TROPINONE MONOCARBOXYLIC ACID DERIVATIVE (57) An optically active tropinonemonocarboxylic tained from natural cocaine, it was proved that the ob- acid ester derivative useful as an intermediate for syn- tained optically active tropinonemonocarboxylic acid es- thesis of optically active tropane derivatives was ob- ter derivative had the same absolute configuration as tained by reacting succindialdehyde with an organic that of natural cocaine. The yield of the optically active amine and acetonedicarboxylic acid ester to obtain a tropinonemonocarboxylic acid ester derivative from the tropinonedicarboxylic acid ester derivative, and then asymmetric dealkoxycarbonylation was 30 to 50 mol%, subjecting this derivative to enzyme-catalyzed asym- and its optical purity was 70 to 97%ee. -
Tropinone Synthesis Via an Atypical Polyketide Synthase and P450-Mediated Cyclization
ARTICLE DOI: 10.1038/s41467-018-07671-3 OPEN Tropinone synthesis via an atypical polyketide synthase and P450-mediated cyclization Matthew A. Bedewitz 1, A. Daniel Jones 2,3, John C. D’Auria 4 & Cornelius S. Barry 1 Tropinone is the first intermediate in the biosynthesis of the pharmacologically important tropane alkaloids that possesses the 8-azabicyclo[3.2.1]octane core bicyclic structure that defines this alkaloid class. Chemical synthesis of tropinone was achieved in 1901 but the 1234567890():,; mechanism of tropinone biosynthesis has remained elusive. In this study, we identify a root- expressed type III polyketide synthase from Atropa belladonna (AbPYKS) that catalyzes the formation of 4-(1-methyl-2-pyrrolidinyl)-3-oxobutanoic acid. This catalysis proceeds through a non-canonical mechanism that directly utilizes an unconjugated N-methyl-Δ1-pyrrolinium cation as the starter substrate for two rounds of malonyl-Coenzyme A mediated decarbox- ylative condensation. Subsequent formation of tropinone from 4-(1-methyl-2-pyrrolidinyl)-3- oxobutanoic acid is achieved through cytochrome P450-mediated catalysis by AbCYP82M3. Silencing of AbPYKS and AbCYP82M3 reduces tropane levels in A. belladonna. This study reveals the mechanism of tropinone biosynthesis, explains the in planta co-occurrence of pyrrolidines and tropanes, and demonstrates the feasibility of tropane engineering in a non- tropane producing plant. 1 Department of Horticulture, Michigan State University, East Lansing, MI 48824, USA. 2 Department of Biochemistry and Molecular Biology, Michigan State University, East Lansing, MI 48824, USA. 3 Department of Chemistry, Michigan State University, East Lansing, MI 48824, USA. 4 Department of Chemistry & Biochemistry, Texas Tech University, Lubbock, TX 79409, USA. -
Silybum Marianum (Milk Thistle) Flower in Vitro and on Human Explants
Molecules 2015, 20, 3549-3564; doi:10.3390/molecules20033549 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Article Anti-Glycation Activities of Phenolic Constituents from Silybum marianum (Milk Thistle) Flower in Vitro and on Human Explants Seoungwoo Shin, Jung-A Lee, Minkyung Kim, Hyunwoo Kum, Eunsun Jung * and Deokhoon Park * Biospectrum Life Science Institute, Eines Platz 11th FL, 442-13 Sangdaewon Dong, Seoungnam City, Gyunggi Do 462-807, Korea; E-Mails: [email protected] (S.S.); [email protected] (J.-A.L.); [email protected] (M.K.); [email protected] (H.K.) * Authors to whom correspondence should be addressed; E-Mails: [email protected] (E.J.); [email protected] (D.P.); Tel.: +82-31-750-9400 (E.J. & D.P.); Fax: +82-31-750-9494 (E.J. & D.P.). Academic Editor: Derek J. McPhee Received: 25 November 2014 / Accepted: 15 February 2015 / Published: 19 February 2015 Abstract: Glycation is an ageing reaction of naturally occurring sugars with dermal proteins, with clinical signs appearing in vivo around age 30, and increasing steadily/regularly with age. The suppleness of the dermis is affected by the formation of bridges between proteins and sugars (Maillard’s reaction). The accumulation of advanced glycation end products (AGEs) in skin plays a very important role in skin ageing. Therefore, natural compounds or extracts that possess antiglycation activities may have great anti-ageing potential. In the present study, Silybum marianum flower extract (SMFE) was demonstrated to possess antiglycation activity. We found that SMFE inhibits glycation reaction between BSA and glucose. In addition, antiglycation activity of SMFE was confirmed in a human skin explants model. -
December Cume
Organic Cumulative Exam December 1, 2001 The Chemistry of Professor Eric Sorenson (PLEASE WRITE ALL ANSWERS ON THE FRONT PAGE OF THE EXAM) Professor Sorenson often derives ideas for his synthetic approaches by speculating on the reactions that are involved in the biosynthesis of the target molecule. That is, his synthetic approaches are "biomimetic". Sorenson also noted that this is not a new approach in organic synthesis. He cited Sir Robert Robinson's synthesis of tropinone. Long, long ago, Robinson took heed of the suggestion that enzymatic Mannich reactions might be involved in the biosynthesis of some alkaloids and used a Mannich reaction to prepare tropinone. (J. Chem. Soc. 1917, 762) 1. Give the structure of tropinone and show a detailed mechanism for the reaction: Hint: Remember that intramolecular reactions are faster than analogous intermolecular reactions. O O H+ H + CH3NH2 + H O Tropinone Hint: formula C8H13NO 2. Some questions regarding Professor Sorenson's synthesis of (-)-hispidospermidin (shown below): J. Am. Chem. Soc. 2000, 122, 9556. Reagents and conditions: (a) 2,4,6-triisopropylbenzenesulfonyl hydrazide, HCl (1.2 equiv), CH3CN, room temperature, 75%. (b) n-BuLi (2.05 equiv), Et2O/THF, -78 to -20 C; then MgBr2·OEt2, -78 C; then 7, -78 C to room temperature, 55% from 8. (c) SEMCl, n-Bu4NI, i-Pr2NEt, CH2Cl2, 50 C, ca. 100%. (d) Dibal-H, toluene, -78 C, 93%. (e) (COCl)2, DMSO, CH2Cl2, -78 C; then i-Pr2NEt, -78 C to room temperature, ca. 100%. (f) AcOH, room temperature, 2 d, 83% or AcOH, 80 C, 3 h, 87%. (g) (COCl)2, DMSO, CH2Cl2, -78 C; then i-Pr2NEt, -78 C to room temperature, ca. -
Toxicological Profile for Hydrazines. US Department Of
TOXICOLOGICAL PROFILE FOR HYDRAZINES U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Agency for Toxic Substances and Disease Registry September 1997 HYDRAZINES ii DISCLAIMER The use of company or product name(s) is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry. HYDRAZINES iii UPDATE STATEMENT Toxicological profiles are revised and republished as necessary, but no less than once every three years. For information regarding the update status of previously released profiles, contact ATSDR at: Agency for Toxic Substances and Disease Registry Division of Toxicology/Toxicology Information Branch 1600 Clifton Road NE, E-29 Atlanta, Georgia 30333 HYDRAZINES vii CONTRIBUTORS CHEMICAL MANAGER(S)/AUTHOR(S): Gangadhar Choudhary, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Hugh IIansen, Ph.D. ATSDR, Division of Toxicology, Atlanta, GA Steve Donkin, Ph.D. Sciences International, Inc., Alexandria, VA Mr. Christopher Kirman Life Systems, Inc., Cleveland, OH THE PROFILE HAS UNDERGONE THE FOLLOWING ATSDR INTERNAL REVIEWS: 1 . Green Border Review. Green Border review assures the consistency with ATSDR policy. 2 . Health Effects Review. The Health Effects Review Committee examines the health effects chapter of each profile for consistency and accuracy in interpreting health effects and classifying end points. 3. Minimal Risk Level Review. The Minimal Risk Level Workgroup considers issues relevant to substance-specific minimal risk levels (MRLs), reviews the health effects database of each profile, and makes recommendations for derivation of MRLs. HYDRAZINES ix PEER REVIEW A peer review panel was assembled for hydrazines. The panel consisted of the following members: 1. Dr. -
Synthetic and Naturally Occurring Hydrazines As Possible Cancer Causative Agents
[CANCER RESEARCH 35, 3693-3697 December 1975] Synthetic and Naturally Occurring Hydrazines as Possible Cancer Causative Agents Bela Toth' The Eppley Institute for Research in Cancer, University of Nebraska Medical Center, Omaha, Nebraska 68105 SUMMARY SYNTHETIC HYDRAZINES The various synthetic substituted hydrazines, which cause tumors in animals, are briefly enumerated. To date, 19 of Studies on the carcinogenic potentialities of synthetic them have proved to be tumorigenic in animals. A number substituted hydrazines began in 1962, when it was shown of these chemicals are found today in the environment, in that the base compound hydrazine sulfate induced lung industry, in agriculture, and in medicine, and the human neoplasms in mice (1). Subsequently, a series of hydrazine population is exposed to a certain degree to some of them. derivatives were investigated in various laboratories for Hydrazine also occurs in nature in tobacco and tobacco tumor-inducing capabilities. These studies clearly demon smoke. The three other naturally occurring hydrazine strated that these chemicals are indeed powerful tumori compounds are N-methyl-N-formylhydrazine, which oc genic substances in mice, hamsters, and rats, due to their curs in the wild edible mushroom, Gyromitra esculenta, tumor-inducing abilities in the intestines, brain, lungs, and @-N-[―y-L(+)-glutamylJ-4-hydroxymethylphenyl blood vessels, liver, breasts, kidneys, etc. Now, we know of hydrazine and 4-hydroxymethylphenylhydrazine, whkh 19 hydrazine derivatives that have been shown to be tumor are found in the commonly eaten cultivated mushroom, inducers. These include, in addition to hydrazine (1, 32), Agaricus bisporus. Tumorigenesis studies with the natu methyl- (35, 40), 1,2-dimethyl- (6, 27, 36, 46, 52), 1,1- rally occurring hydrazines are in progress. -
Tropane and Granatane Alkaloid Biosynthesis: a Systematic Analysis
Office of Biotechnology Publications Office of Biotechnology 11-11-2016 Tropane and Granatane Alkaloid Biosynthesis: A Systematic Analysis Neill Kim Texas Tech University Olga Estrada Texas Tech University Benjamin Chavez Texas Tech University Charles Stewart Jr. Iowa State University, [email protected] John C. D’Auria Texas Tech University Follow this and additional works at: https://lib.dr.iastate.edu/biotech_pubs Part of the Biochemical and Biomolecular Engineering Commons, and the Biotechnology Commons Recommended Citation Kim, Neill; Estrada, Olga; Chavez, Benjamin; Stewart, Charles Jr.; and D’Auria, John C., "Tropane and Granatane Alkaloid Biosynthesis: A Systematic Analysis" (2016). Office of Biotechnology Publications. 11. https://lib.dr.iastate.edu/biotech_pubs/11 This Article is brought to you for free and open access by the Office of Biotechnology at Iowa State University Digital Repository. It has been accepted for inclusion in Office of Biotechnology Publicationsy b an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. Tropane and Granatane Alkaloid Biosynthesis: A Systematic Analysis Abstract The tropane and granatane alkaloids belong to the larger pyrroline and piperidine classes of plant alkaloids, respectively. Their core structures share common moieties and their scattered distribution among angiosperms suggest that their biosynthesis may share common ancestry in some orders, while they may be independently derived in others. Tropane and granatane alkaloid diversity arises from the myriad modifications occurring ot their core ring structures. Throughout much of human history, humans have cultivated tropane- and granatane-producing plants for their medicinal properties. This manuscript will discuss the diversity of their biological and ecological roles as well as what is known about the structural genes and enzymes responsible for their biosynthesis. -
Receptor Antagonist
Europäisches Patentamt *EP001604983A1* (19) European Patent Office Office européen des brevets (11) EP 1 604 983 A1 (12) EUROPEAN PATENT APPLICATION published in accordance with Art. 158(3) EPC (43) Date of publication: (51) Int Cl.7: C07D 217/26, C07D 403/06, 14.12.2005 Bulletin 2005/50 C07D 403/12, C07D 491/113, A61K 31/472, A61K 31/4741, (21) Application number: 04721010.9 A61P 43/00, A61P 29/00, (22) Date of filing: 16.03.2004 A61P 35/00, A61P 15/00, A61P 15/08, A61P 15/10, A61P 15/14, A61P 37/00, A61P 5/48, A61P 3/10, A61P 3/02, A61P 3/06, A61P 17/00, A61P 19/02, A61P 19/08 (86) International application number: PCT/JP2004/003496 (87) International publication number: WO 2004/083184 (30.09.2004 Gazette 2004/40) (84) Designated Contracting States: • HINUMA, Shuji AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Tsukuba-shi, Ibaraki 3050821 (JP) HU IE IT LI LU MC NL PL PT RO SE SI SK TR • KANZAKI, Naoyuki, c/o Takeda Pharmaceutical Designated Extension States: Yodogawa-ku, Osaka-shi, Osaka (JP) AL LT LV MK • BANNO, Yoshihiro, c/o Takeda Pharmaceutical Yodogawa-ku, Osaka-shi, Osaka (JP) (30) Priority: 17.03.2003 JP 2003072709 • YOSHIDA, Hiromi Yuki-gun, Ibar aki 3002741 (JP) (71) Applicant: Takeda Pharmaceutical Company • MATSUMOTO, Hirokazu Limited Tsukuba-shi, Ibaraki 3050821 (JP) Osaka 541-0045 (JP) (74) Representative: Rickard, Timothy Mark Adrian (72) Inventors: Takeda Euro IP Department, • ITOH, Fumio 11-12 Charles II Street Tsukuba-shi, Ibaraki 3050821 (JP) London SW1Y 4QU (GB) (54) RECEPTOR ANTAGONIST (57) A compound represented by